(VIANEWS) – The Market ended the session with MAUNA KEA TECH (MKEA.PA) rising 17.42% to €0.70 on Friday, after two sequential sessions in a row of losses. CAC 40 jumped 0.51% to €7,577.00, following the last session’s downward trend on what was a somewhat positive trend exchanging session today.
MAUNA KEA TECH’s last close was €0.60, 39.9% below its 52-week high of €0.99.
About MAUNA KEA TECH
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, MAUNA KEA TECH has a trailing twelve months EPS of €-0.27.
Yearly Top and Bottom Value
MAUNA KEA TECH’s stock is valued at €0.70 at 22:34 EST, way under its 52-week high of €0.99 and way above its 52-week low of €0.37.
Moving Average
MAUNA KEA TECH’s worth is way higher than its 50-day moving average of €0.51 and way higher than its 200-day moving average of €0.58.
More news about MAUNA KEA TECH (MKEA.PA).
